SPDR S&P Biotech ETF $XBI Stock: Kingswood Wealth Advisors LLC Boosts Holdings

Kingswood Wealth Advisors LLC grew its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 33.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 19,218 shares of the exchange traded fund’s stock after purchasing an additional 4,848 shares during the period. Kingswood Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $3,030,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $19,270,000. Ayalon Insurance Comp Ltd. raised its stake in shares of SPDR S&P Biotech ETF by 71.9% during the 3rd quarter. Ayalon Insurance Comp Ltd. now owns 95,600 shares of the exchange traded fund’s stock worth $15,074,000 after purchasing an additional 40,000 shares during the period. Continuum Advisory LLC grew its position in SPDR S&P Biotech ETF by 389.1% during the second quarter. Continuum Advisory LLC now owns 18,013 shares of the exchange traded fund’s stock valued at $2,851,000 after buying an additional 14,330 shares during the period. Syon Capital LLC grew its position in SPDR S&P Biotech ETF by 67.9% during the second quarter. Syon Capital LLC now owns 23,562 shares of the exchange traded fund’s stock valued at $3,729,000 after buying an additional 9,530 shares during the period. Finally, TD Waterhouse Canada Inc. increased its holdings in SPDR S&P Biotech ETF by 535.1% during the second quarter. TD Waterhouse Canada Inc. now owns 5,265 shares of the exchange traded fund’s stock worth $824,000 after buying an additional 4,436 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $150.47 on Tuesday. The company has a market capitalization of $10.50 billion, a PE ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 52-week low of $106.30 and a 52-week high of $169.89. The company has a 50-day simple moving average of $157.13 and a 200 day simple moving average of $140.94.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.